This recall was expanded on January 29, 2019. This recall affects products that have expired during 2019. There have been no other ibuprofen recalls since January 2019, according to the FDA. The article has been corrected to reflect this information.
(WTNH) — New Jersey-based pharmaceutical company, Tris Pharma Inc., has expanded its voluntary recall of its infants’ liquid ibuprofen after discovering higher concentrations of the medication in some packages.
The company added three additional lots of Ibuprofen Oral Suspension Drops, USP, 50 mg per 1.25 mL, to the retail (pharmacy) level.
The FDA reports infants already susceptible to the adverse effects of ibuprofen may be slightly higher at risk if they receive medication from an impacted bottle.
There is also the remote probability that infants, who may be more susceptible to a higher potency level of drug, may be more vulnerable to permanent NSAID-associated renal injury.
Altogether, the company has recalled six lots of the medicine and found that they contained 10% more ibuprofen than the specified limit.
The impacted items were sold at Walmart, CVS, and Family Dollar.
The products should not be used but thrown out or brought to the store where it was purchased from for a full refund.
Consumers with questions regarding the recall may contact Tris Customer Service by (732) 940-0358 or via email at email@example.com.
- HCSO: Man charged after biting deputy twice
- Lady Vols take down Ole Miss 77-66 on senior night
- KFC employee in Yadkinville, N.C. tells News Channel 11 she reported possible Evelyn sighting to TBI on Tuesday
- CDC: It’s not if, but when coronavirus spreads into clusters of cases in U.S.
- Trump administration prepares for coronavirus; lawmakers react to appointment of VP